SG Americas Securities LLC Boosts Stock Position in Healthpeak Properties, Inc. $DOC

Key Points

• SG Americas Securities raised its stake in Healthpeak by 2,416.7% in Q4, buying 1,109,146 shares to hold 1,155,041 shares (about 0.17% of the company) worth $18.57 million.
• Healthpeak beat Q4 estimates with $0.47 EPS (vs. $0.45) and $719.4M revenue (vs. $685.1M) and issued FY2026 guidance of 1.700–1.740 EPS
• The company declared a monthly dividend of $0.1017 (ex-dividend Mar 17, payable Mar 31) implying a ~7.4% yield, though a reported dividend payout ratio of 1,220% raises questions about sustainability.

SG Americas Securities LLC raised its holdings in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 2,416.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,155,041 shares of the real estate investment trust's stock after purchasing an additional 1,109,146 shares during the quarter. SG Americas Securities LLC owned 0.17% of Healthpeak Properties worth $18,573,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. Vanderbilt University purchased a new position in Healthpeak Properties in the third quarter valued at approximately $1,263,000. Northside Capital Management LLC purchased a new stake in Healthpeak Properties in the third quarter worth $6,123,000. Baird Financial Group Inc. increased its position in Healthpeak Properties by 38.5% in the second quarter. Baird Financial Group Inc. now owns 402,466 shares of the real estate investment trust's stock worth $7,047,000 after buying an additional 111,807 shares during the last quarter. Argent Advisors Inc. bought a new stake in shares of Healthpeak Properties in the third quarter valued at $1,536,000. Finally, Twin City Private Wealth LLC bought a new stake in shares of Healthpeak Properties in the third quarter valued at $1,148,000. 93.57% of the stock is owned by hedge funds and other institutional investors.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $16.54 on Friday. The company has a 50 day moving average of $17.21 and a 200 day moving average of $17.51. The company has a current ratio of 2.82, a quick ratio of 2.82 and a debt-to-equity ratio of 1.21. The stock has a market cap of $11.50 billion, a P/E ratio of 165.45, a P/E/G ratio of 8.99 and a beta of 1.12. Healthpeak Properties, Inc. has a 12 month low of $15.71 and a 12 month high of $20.40.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analysts' expectations of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business's quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Announces Dividend

The business also recently disclosed a monthly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.1017 per share. The ex-dividend date is Tuesday, March 17th. This represents a c) annualized dividend and a dividend yield of 7.4%. Healthpeak Properties's dividend payout ratio (DPR) is 1,220.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the company. Wall Street Zen cut Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Saturday. Weiss Ratings upgraded shares of Healthpeak Properties from a "sell (d+)" rating to a "hold (c-)" rating in a research report on Monday, January 26th. Cantor Fitzgerald set a $17.00 target price on shares of Healthpeak Properties in a research note on Monday, January 5th. Argus lowered shares of Healthpeak Properties from a "buy" rating to a "hold" rating in a research report on Thursday, February 5th. Finally, Jefferies Financial Group cut shares of Healthpeak Properties from a "buy" rating to a "hold" rating and dropped their price target for the company from $21.00 to $17.00 in a research note on Monday, December 15th. Six investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $19.42.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.